Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LUNGPulmonx Corp

Nasdaq · CIK 0001127537
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts369

Identity from submissions API

NamePulmonx Corp
CIK0001127537
TickersLUNG
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-364-0400
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • PULMONX (2003-12-09T05:00:00.000Z → 2012-02-07T05:00:00.000Z)
Business address
700 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA
Mailing address
700 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

451 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000763212-26-000032 005-91741 261526779 34 7332
2026-11-03 10-Q 10-Q 0001127537-26-000048 001-39562 261518347 34 8214466 1 1
2026-10-27 8-K 8-K 2.02,9.01 0001127537-26-000042 001-39562 261490433 34 363665 1 1
2026-09-03 4 xslF345X06/form4-09032026_100945.xml 0001805624-26-000004 7918
2026-09-03 4 xslF345X06/form4-09032026_100954.xml 0002098678-26-000004 10168
2026-09-03 4 xslF345X06/form4-09032026_100913.xml 0001354228-26-000005 10160
2026-09-03 4 xslF345X06/form4-09032026_100924.xml 0001804146-26-000004 10154
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000266 005-91741 261275071 34 11997
2026-08-04 10-Q 10-Q 0001127537-26-000039 001-39562 261239648 34 8105647 1 1
2026-07-29 8-K 8-K 2.02 0001127537-26-000035 001-39562 261217429 34 366516 1 1
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002934 005-91741 261216996 34 10796
2026-06-09 4 xslF345X06/form4-06092026_100638.xml 0001644557-26-000022 5281
2026-06-09 4 xslF345X06/form4-06092026_100606.xml 0001034413-26-000002 5322
2026-06-09 4 xslF345X06/form4-06092026_090604.xml 0001402459-26-000002 5261
2026-06-09 4 xslF345X06/form4-06092026_090601.xml 0001817552-26-000002 5296
2026-06-09 4 xslF345X06/form4-06092026_090603.xml 0001876368-26-000002 5226
2026-06-09 4 xslF345X06/form4-06092026_090640.xml 0001222358-26-000002 6256
2026-06-04 8-K 8-K 5.07 0001127537-26-000031 001-39562 261064855 34 153887 1 1
2026-06-03 4 xslF345X06/form4-06032026_080611.xml 0002098678-26-000002 10167
2026-06-03 4 xslF345X06/form4-06032026_080624.xml 0001354228-26-000003 10160
2026-06-03 4 xslF345X06/form4-06032026_080635.xml 0001804146-26-000002 10154
2026-06-03 4 xslF345X06/form4-06032026_080643.xml 0001805624-26-000002 9478
2026-05-19 SD SD 0001127537-26-000028 001-39562 26995465 34 29287
2026-05-04 10-Q 10-Q 0001127537-26-000025 001-39562 26938292 34 7545533 1 1
2026-04-29 8-K 8-K 2.02 0001127537-26-000020 001-39562 26916179 34 304108 1 1
2026-04-22 ARS ARS 0001140361-26-016111 001-39562 26883842 34 2086925
2026-04-22 DEFA14A DEFA14A 0001140361-26-016107 001-39562 26883817 34 2346506
2026-04-22 DEF 14A DEF 14A 0001140361-26-016105 001-39562 26883796 34 5233302 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002191 005-91741 26803236 34 7185
2026-03-10 S-8 S-8 0001127537-26-000017 333-294193 26740534 33 392866 1 1
2026-03-10 10-K 10-K 0001127537-26-000015 001-39562 26740301 34 24600921 1 1
2026-03-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-025237 005-91741 26735953 34 33343
2026-03-05 8-K 8-K 1.01,1.02,2.03,3.02,9.01 0001193125-26-092064 001-39562 26723506 34 1362656 1 1
2026-03-04 4 xslF345X05/form4-03052026_120355.xml 0002098678-26-000001 11754
2026-03-04 4 xslF345X05/form4-03052026_120316.xml 0001805624-26-000001 9307
2026-03-04 4 xslF345X05/form4-03052026_120358.xml 0001804146-26-000001 11741
2026-03-04 4 xslF345X05/form4-03052026_120356.xml 0001354228-26-000002 11748
2026-03-04 8-K 8-K 2.02 0001127537-26-000003 001-39562 26721342 34 340998 1 1
2026-01-22 144 xsl144X01/primary_doc.xml 0001950047-26-000623 001-39562 26551554 33 9258
2026-01-15 144 xsl144X01/primary_doc.xml 0001950047-26-000493 001-39562 26537188 33 6205
2026-01-14 144 xsl144X01/primary_doc.xml 0001950047-26-000423 001-39562 26533947 33 6680
2025-12-10 3 xslF345X02/form3-12102025_111251.xml 0002098678-25-000002 18927
2025-12-09 4 xslF345X05/form4-12092025_101256.xml 0001402459-25-000005 5357
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009972 001-39562 251557185 33 6611
2025-12-03 4 xslF345X05/form4-12042025_121243.xml 0001805624-25-000005 11873
2025-12-03 4 xslF345X05/form4-12042025_121203.xml 0001804146-25-000004 10016
2025-12-03 4 xslF345X05/form4-12042025_121248.xml 0001670118-25-000006 7589
2025-12-03 4 xslF345X05/form4-12042025_121229.xml 0001354228-25-000006 10022
2025-11-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003379 333-290560 251523694 33 1818
2025-11-24 CORRESP filename1.htm 0001193125-25-294067 14113
2025-11-24 S-3/A S-3/A 0001193125-25-293749 333-290560 251513606 33 331824
2025-11-24 S-8 S-8 0001127537-25-000066 333-291752 251513106 33 594247 1 1
2025-11-18 UPLOAD filename1.pdf 0000000000-25-010820 333-290560 40257
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000763212-25-000009 005-91741 251480604 34 7330
2025-11-12 10-Q 10-Q 0001127537-25-000059 001-39562 251473200 34 7707676 1 1
2025-11-12 8-K 8-K 2.02 0001127537-25-000058 001-39562 251472579 34 309136 1 1
2025-11-10 3 xslF345X02/form3-11102025_101123.xml 0001670118-25-000004 10749
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002915 005-91741 251461160 34 11414
2025-10-27 8-K 8-K 2.02,5.02,9.01 0001127537-25-000052 001-39562 251419905 34 548663 1 1
2025-09-26 S-3 S-3 0001193125-25-220800 333-290560 251351451 33 564055 1 1
2025-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002259 005-91741 251299154 34 11549
2025-09-03 4 xslF345X05/form4-09032025_090900.xml 0001415889-25-023574 6946
2025-09-03 4 xslF345X05/form4-09032025_090938.xml 0001415889-25-023573 6859
2025-09-03 4 xslF345X05/form4-09032025_090934.xml 0001415889-25-023572 10016
2025-09-03 4 xslF345X05/form4-09032025_090929.xml 0001415889-25-023571 10022
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002094 005-91741 251188442 34 11142
2025-08-01 10-Q 10-Q 0001127537-25-000045 001-39562 251177107 34 7886906 1 1
2025-07-30 8-K 8-K 2.02 0001127537-25-000041 001-39562 251167010 34 308564 1 1
2025-06-13 4 xslF345X05/form4-06132025_090602.xml 0001415889-25-017271 5205
2025-06-13 144 xsl144X01/primary_doc.xml 0001949846-25-000284 001-39562 251045282 33 4288
2025-06-12 144 xsl144X01/primary_doc.xml 0001950047-25-004245 001-39562 251043879 33 4807
2025-06-05 4 xslF345X05/form4-06062025_120631.xml 0001415889-25-015859 5109
2025-06-04 4 xslF345X05/form4-06042025_100603.xml 0001415889-25-015652 12025
2025-06-04 4 xslF345X05/form4-06042025_100628.xml 0001415889-25-015651 12065
2025-06-04 4 xslF345X05/form4-06042025_100642.xml 0001415889-25-015650 6694
2025-06-04 4 xslF345X05/form4-06042025_100609.xml 0001415889-25-015649 12107
2025-06-04 4 xslF345X05/form4-06042025_100628.xml 0001415889-25-015646 6652
2025-06-04 4 xslF345X05/form4-06042025_100638.xml 0001415889-25-015645 12042
2025-06-04 4 xslF345X05/form4-06042025_100657.xml 0001415889-25-015644 12113
2025-06-04 4 xslF345X05/form4-06042025_100619.xml 0001415889-25-015643 11714
2025-06-04 4 xslF345X05/form4-06042025_100644.xml 0001415889-25-015640 11720
2025-06-04 4 xslF345X05/form4-06042025_100633.xml 0001415889-25-015639 5258
2025-06-04 4 xslF345X05/form4-06042025_090625.xml 0001415889-25-015636 13350
2025-05-30 SD SD 0001127537-25-000032 001-39562 251012341 34 29340
2025-05-23 8-K 8-K 5.07 0001127537-25-000028 001-39562 25978506 34 154875 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-003062 005-91741 25940521 34 7328
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001554 005-91741 25933303 34 11573
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000374 005-91741 25920122 34 12005
2025-05-02 10-Q 10-Q 0001127537-25-000026 001-39562 25908832 34 7546080 1 1
2025-04-30 8-K 8-K 2.02 0001127537-25-000023 001-39562 25895233 34 280418 1 1
2025-04-24 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001639 005-91741 25864492 34 10818
2025-04-08 ARS ARS 0001140361-25-012820 001-39562 25821908 34 14994926
2025-04-08 DEFA14A DEFA 14A 0001140361-25-012817 001-39562 25821885 34 1264897
2025-04-08 DEF 14A DEF 14A 0001140361-25-012814 001-39562 25821877 34 5018032 1 1
2025-03-21 4 xslF345X05/form4-03212025_100324.xml 0001415889-25-008792 5336
2025-03-20 144 xsl144X01/primary_doc.xml 0001950047-25-002080 001-39562 25756702 33 6964
2025-03-05 4 xslF345X05/form4-03052025_110357.xml 0001415889-25-007043 12692
2025-03-05 4 xslF345X05/form4-03052025_110320.xml 0001415889-25-007042 16114
2025-03-05 4 xslF345X05/form4-03052025_110343.xml 0001415889-25-007039 21071
2025-03-05 4 xslF345X05/form4-03052025_110324.xml 0001415889-25-007034 18669
2025-03-03 144 xsl144X01/primary_doc.xml 0001950047-25-001454 001-39562 25698780 33 9545
2025-02-25 S-8 S-8 0001127537-25-000014 333-285225 25664397 33 253011
2025-02-25 10-K 10-K 0001127537-25-000012 001-39562 25663734 34 24331323 1 1
2025-02-24 4 xslF345X05/form4-02242025_100254.xml 0001415889-25-005323 7343
2025-02-20 144 xsl144X01/primary_doc.xml 0001950047-25-001088 001-39562 25645765 33 6963
2025-02-19 8-K 8-K 2.02 0001127537-25-000003 001-39562 25640035 34 327329 1 1
2025-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000213 005-91741 25586551 34 12029
2025-01-21 4 xslF345X05/form4-01212025_100113.xml 0001415889-25-001819 6847
2025-01-17 144 xsl144X01/primary_doc.xml 0001950047-25-000323 001-39562 25538895 33 6247
2025-01-16 144 xsl144X01/primary_doc.xml 0001950047-25-000315 001-39562 25536139 33 6253
2024-12-04 4 xslF345X05/form4-12042024_111238.xml 0001415889-24-028319 10018
2024-12-04 4 xslF345X05/form4-12042024_111215.xml 0001415889-24-028318 10036
2024-11-26 4 xslF345X05/form4-11262024_111118.xml 0001415889-24-027785 5338
2024-11-22 144 xsl144X01/primary_doc.xml 0001950047-24-009002 001-39562 241490151 33 6264
2024-11-14 SC 13G/A PULMONX CORPORATION 0000902664-24-006641 005-91741 241465285 34 73427
2024-11-12 SC 13G/A filing.txt 0000315066-24-002851 005-91741 241444979 34 8270
2024-11-08 SC 13G/A MS AMENDMENT 0000895421-24-000599 005-91741 241438534 34 17619
2024-11-01 10-Q 10-Q 0001127537-24-000087 001-39562 241419386 34 8446211 1 1
2024-10-30 8-K 8-K 2.02 0001127537-24-000082 001-39562 241410410 34 321359 1 1
2024-10-21 4 xslF345X05/form4-10212024_091042.xml 0001415889-24-025464 5338
2024-10-17 144 xsl144X01/primary_doc.xml 0001950047-24-007788 001-39562 241377826 33 5541
2024-09-18 4 xslF345X05/form4-09182024_100916.xml 0001415889-24-023654 5338
2024-09-12 144 xsl144X01/primary_doc.xml 0001950047-24-007006 001-39562 241295373 33 4821
2024-09-05 4 xslF345X05/form4-09052024_100923.xml 0001415889-24-022972 10018
2024-09-05 4 xslF345X05/form4-09052024_100923.xml 0001415889-24-022971 10036
2024-08-22 4 xslF345X05/form4-08222024_100814.xml 0001415889-24-022065 5233
2024-08-02 10-Q 10-Q 0001127537-24-000077 001-39562 241171426 34 8278352 1 1
2024-07-31 8-K 8-K 2.02 0001127537-24-000073 001-39562 241162021 34 320961 1 1
2024-06-26 4 xslF345X05/form4-06262024_100621.xml 0001415889-24-018262 4863
2024-06-24 144 xsl144X01/primary_doc.xml 0001950047-24-004993 001-39562 241064651 33 6898
2024-06-05 4 xslF345X05/form4-06052024_100658.xml 0001415889-24-015642 5147
2024-06-05 4 xslF345X05/form4-06052024_100636.xml 0001415889-24-015641 5188
2024-06-05 4 xslF345X05/form4-06052024_100604.xml 0001415889-24-015640 5947
2024-06-05 4 xslF345X05/form4-06052024_100615.xml 0001415889-24-015638 5092
2024-06-05 4 xslF345X05/form4-06052024_090644.xml 0001415889-24-015634 10036
2024-06-05 4 xslF345X05/form4-06052024_090634.xml 0001415889-24-015632 10018
2024-06-05 4 xslF345X05/form4-06052024_090637.xml 0001415889-24-015628 5104
2024-06-05 4 xslF345X05/form4-06052024_090656.xml 0001415889-24-015625 6422
2024-06-05 4 xslF345X05/form4-06052024_090612.xml 0001415889-24-015623 5162
2024-05-31 SD SD 0001127537-24-000068 001-39562 241010311 34 29709
2024-05-23 4 xslF345X05/form4-05232024_100518.xml 0001415889-24-014373 4862
2024-05-23 8-K 8-K 1.01,9.01 0001127537-24-000063 001-39562 24978635 34 1474241 1 1
2024-05-22 144 xsl144X01/primary_doc.xml 0001950047-24-004072 001-39562 24974217 33 6898
2024-05-17 8-K 8-K 5.07 0001127537-24-000057 001-39562 24959480 34 161756 1 1
2024-05-07 4 xslF345X05/form4-05072024_090522.xml 0001415889-24-012499 7393
2024-05-03 S-8 S-8 0001127537-24-000054 333-279112 24913591 33 364555
2024-05-03 10-Q 10-Q 0001127537-24-000052 001-39562 24913209 34 7622166 1 1
2024-05-01 8-K 8-K 2.02 0001127537-24-000045 001-39562 24903077 34 281052 1 1
2024-04-24 4 xslF345X05/form4-04242024_100440.xml 0001415889-24-011468 4862
2024-04-22 144 xsl144X01/primary_doc.xml 0001950047-24-003162 001-39562 24861706 33 6898
2024-04-09 3 xslF345X02/form3-04092024_100420.xml 0001415889-24-010607 10348
2024-04-05 ARS ARS 0001140361-24-018319 001-39562 24826627 34 2541541
2024-04-05 DEFA14A DEFA14A 0001140361-24-018315 001-39562 24826559 34 2943340
2024-04-05 DEF 14A DEF 14A 0001140361-24-018313 001-39562 24826545 34 2676725
2024-04-02 8-K 8-K 5.02,8.01,9.01 0001127537-24-000039 001-39562 24814257 34 744773 1 1
2024-03-26 4 xslF345X05/form4-03262024_090353.xml 0001415889-24-009142 4862
2024-03-22 144 xsl144X01/primary_doc.xml 0001950047-24-002648 001-39562 24775506 33 6899
2024-03-19 4 xslF345X05/form4-03192024_100303.xml 0001415889-24-008639 7426
2024-03-19 3 xslF345X02/form3-03192024_100306.xml 0001415889-24-008634 10085
2024-03-15 S-8 S-8 0001127537-24-000034 333-277962 24752677 33 374323
2024-03-11 SC 13G/A filing.txt 0000315066-24-001683 005-91741 24736614 34 8264
2024-03-07 4/A xslF345X05/form4a-03082024_010315.xml 0001415889-24-007234 7553
2024-03-07 4/A xslF345X05/form4a-03082024_120350.xml 0001415889-24-007232 7492
2024-03-07 4/A xslF345X05/form4a-03082024_120320.xml 0001415889-24-007230 7571
2024-03-05 4 xslF345X05/form4-03052024_110331.xml 0001415889-24-006846 12289
2024-03-05 4 xslF345X05/form4-03052024_110310.xml 0001415889-24-006843 12431
2024-03-05 4 xslF345X05/form4-03052024_110357.xml 0001415889-24-006841 12307
2024-03-05 4 xslF345X05/form4-03052024_110301.xml 0001415889-24-006829 8525
2024-02-29 SC 13G PULMONX CORP. 0000902664-24-002107 005-91741 24704285 34 84939
2024-02-27 10-K 10-K 0001127537-24-000024 001-39562 24686626 34 24357667 1 1
2024-02-26 4 xslF345X05/form4-02262024_110219.xml 0001415889-24-005309 4863
2024-02-22 144 xsl144X01/primary_doc.xml 0001950047-24-001306 001-39562 24665340 33 6900
2024-02-21 8-K 8-K 2.02 0001127537-24-000013 001-39562 24659458 34 324550 1 1
2024-02-21 8-K 8-K 5.02,8.01,9.01 0001127537-24-000012 001-39562 24659381 34 769186 1 1
2024-02-16 4 xslF345X05/form4-02172024_120205.xml 0001415889-24-004241 5357
2024-02-15 144 xsl144X01/primary_doc.xml 0001950047-24-001018 001-39562 24644817 33 6976
2024-02-14 SC 13G/A PULMONX CORPORATION 0000902664-24-001525 005-91741 24631957 34 89696
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021771 005-91741 24629387 34 13088
2024-02-13 SC 13G/A CHAMPLAIN 13G TICKER LUNG 0001315478-24-000021 005-91741 24625351 34 10742
2024-02-12 SC 13G/A e619250_sc13ga-pulmonx.htm 0001193805-24-000188 005-91741 24621500 34 100797
2024-02-12 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-24-001097 005-91741 24619782 34 27958
2024-02-09 SC 13G/A MS AMENDMENT 0000895421-24-000106 005-91741 24612772 34 12735
2024-02-09 SC 13G filing.txt 0000315066-24-001444 005-91741 24612050 34 8259
2024-01-31 144 xsl144X01/primary_doc.xml 0001950047-24-000540 001-39562 24583439 33 4848
2024-01-25 SC 13G/A us7458481014_012524.txt 0001086364-24-003723 005-91741 24562899 34 13591
2024-01-24 4 xslF345X05/form4-01242024_100127.xml 0001415889-24-001766 4863
2024-01-22 4 xslF345X05/form4-01222024_110115.xml 0001415889-24-001651 5357
2024-01-22 144 xsl144X01/primary_doc.xml 0001950047-24-000410 001-39562 24549155 33 7596
2024-01-18 144 xsl144X01/primary_doc.xml 0001950047-24-000371 001-39562 24542575 33 6276
2023-12-27 4 FORM 4 SUBMISSION 0001209191-23-059779 4941
2023-12-22 4 FORM 4 SUBMISSION 0001209191-23-059614 5434
2023-12-22 144 xsl144X01/primary_doc.xml 0001950047-23-006441 001-39562 231510157 33 6900
2023-12-21 144 xsl144X01/primary_doc.xml 0001950047-23-006412 001-39562 231505879 33 5575
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057512 8397
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057510 10036
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057508 8408
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057506 8395
2023-11-27 4 FORM 4 SUBMISSION 0001209191-23-056719 4836
2023-11-22 144 xsl144X01/primary_doc.xml 0001950047-23-005343 001-39562 231433812 33 7492
2023-11-03 10-Q 10-Q 0001127537-23-000048 001-39562 231376262 34 7880539 1 1
2023-10-30 8-K 8-K 2.02 0001127537-23-000042 001-39562 231360242 34 321634 1 1
2023-10-25 4 FORM 4 SUBMISSION 0001209191-23-053594 4835
2023-10-23 144 xsl144X01/primary_doc.xml 0001950047-23-004593 001-39562 231340532 33 6795
2023-10-19 3 FORM 3 SUBMISSION 0001209191-23-053181 12585
2023-10-10 8-K 8-K 2.02,5.02,7.01,9.01 0001193125-23-253468 001-39562 231317992 34 177614 1 1
2023-09-26 4 FORM 4 SUBMISSION 0001209191-23-050608 4836
2023-09-22 144 xsl144X01/primary_doc.xml 0001950047-23-004237 001-39562 231271932 33 6099
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048516 8428
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048511 8397
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048493 8408
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048487 8395
2023-08-25 4 FORM 4 SUBMISSION 0001209191-23-047388 4836
2023-08-04 10-Q 10-Q 0001127537-23-000036 001-39562 231144325 34 7736985 1 1
2023-08-02 8-K 8-K 2.02 0001127537-23-000032 001-39562 231135522 34 321028 1 1
2023-07-24 4 FORM 4 SUBMISSION 0001209191-23-043254 5329
2023-07-20 144 xsl144X01/primary_doc.xml 0001950047-23-002472 001-39562 231100349 33 6077
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038576 5329
2023-06-15 144 xsl144X01/primary_doc.xml 0001950047-23-001707 001-39562 231019121 33 5379
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034010 8427
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034008 5021
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034007 8396
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034006 5104
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034003 5021
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-034001 8407
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033999 8394
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033988 5880
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033986 5119
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033983 5080
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033981 6351
2023-05-26 SD SD 0001127537-23-000027 001-39562 23963324 34 32749
2023-05-18 8-K 8-K 5.07 0001127537-23-000023 001-39562 23936136 34 184269 1 1
2023-05-09 S-8 S-8 0001127537-23-000021 333-271769 23902222 33 255057
2023-05-08 10-Q 10-Q 0001127537-23-000018 001-39562 23898864 34 7698938 1 1
2023-05-02 8-K 8-K 2.02,9.01 0001127537-23-000014 001-39562 23879007 34 306258 1 1
2023-04-04 ARS ARS 0001193125-23-090964 001-39562 23798656 34 8587156
2023-04-04 DEFA14A DEFA14A 0001193125-23-090961 001-39562 23798584 34 244224
2023-04-04 DEF 14A DEF 14A 0001193125-23-090955 001-39562 23798519 34 587668
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016025 10780
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016021 10957
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016003 10758
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016000 10959
2023-03-01 10-K 10-K 0001127537-23-000011 001-39562 23693528 34 24725531 1 1
2023-02-22 8-K 8-K 2.02,2.03,9.01 0001127537-23-000005 001-39562 23653108 34 350900 1 1
2023-02-14 SC 13G/A lung.txt 0001590144-23-000018 005-91741 23628200 34 10043
2023-02-13 SC 13G e618281_sc13g-pulmonx.htm 0001193805-23-000208 005-91741 23620171 34 99651
2023-02-13 SC 13G/A e618280_sc13ga-pulmonx.htm 0001193805-23-000204 005-91741 23619655 34 98318
2023-02-13 SC 13G/A SEC SCHEDULE 13G 0001422849-23-000126 005-91741 23617796 34 18189
2023-02-13 SC 13G/A CHAMPLAIN 13G TICKER LUNG 0001315478-23-000025 005-91741 23617592 34 10675
2023-02-10 SC 13G MS INITIAL 0000895421-23-000216 005-91741 23610613 34 12607
2023-02-09 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-23-000898 005-91741 23606106 34 27852
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016785 005-91741 23604064 34 12984
2023-01-31 SC 13G/A us7458481014_013123.txt 0001306550-23-005027 005-91741 23571720 34 13368
2023-01-04 SC 13G SCHEDULE 13G 0000899140-23-000014 005-91741 23507677 34 63665
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059855 6602
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059854 6614
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059852 6605
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059842 6636
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059221 4509
2022-11-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-15 16:00:00 9999999995-22-003305 333-268130 221392831 33 1753
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056872 7105
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056871 7070
2022-11-14 S-3/A S-3/A 0001127537-22-000061 333-268130 221385405 33 78140
2022-11-10 4 FORM 4 SUBMISSION 0001209191-22-056449 6129
2022-11-10 CORRESP filename1.htm 0001127537-22-000058 25365
2022-11-09 UPLOAD filename1.pdf 0000000000-22-012240 40280
2022-11-08 10-Q 10-Q 0001127537-22-000053 001-39562 221369306 34 8448510 1 1
2022-11-03 S-3 S-3 0001127537-22-000050 333-268130 221358099 33 1311239
2022-11-03 8-K 8-K 1.01,2.02 0001127537-22-000048 001-39562 221357842 34 326177 1 1
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050572 4781
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048783 6638
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048782 6809
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048781 6616
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048780 6604
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-047057 5484
2022-08-08 10-Q 10-Q 0001127537-22-000037 001-39562 221144800 34 8189504 1 1
2022-08-02 8-K 8-K 2.02,9.01 0001127537-22-000033 001-39562 221128814 34 320573 1 1
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034882 5017
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034327 4976
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034324 5001
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034321 6243
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034317 6606
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034310 6637
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034300 4918
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034297 6602
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034288 6615
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034286 5777
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034280 4918
2022-05-27 8-K 8-K 5.07 0001127537-22-000029 001-39562 22978177 34 190076 1 1
2022-05-25 SC 13G lungusv4.txt 0001590144-22-000022 005-91741 22961867 34 10909
2022-05-18 4 FORM 4 SUBMISSION 0001209191-22-030215 4757
2022-05-10 S-8 S-8 0001127537-22-000026 333-264825 22909789 33 250128
2022-05-09 10-Q 10-Q 0001127537-22-000022 001-39562 22905472 34 7521592 1 1
2022-05-03 8-K 8-K 2.02,9.01 0001127537-22-000015 001-39562 22886979 34 289171 1 1
2022-04-15 DEFA14A DEFA14A 0001193125-22-106795 001-39562 22830136 34 337157
2022-04-15 DEF 14A DEF 14A 0001193125-22-106791 001-39562 22830100 34 885330
2022-04-07 4/A FORM 4/A SUBMISSION 0001209191-22-023688 4042
2022-03-11 4 FORM 4 SUBMISSION 0001209191-22-018263 7074
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015840 8798
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015836 9185
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015828 8949
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015792 8977
2022-03-01 10-K 10-K 0001127537-22-000013 001-39562 22698456 34 29360888 1 1
2022-02-25 8-K/A 8-K/A 2.02,9.01 0001127537-22-000009 001-39562 22682267 34 324852 1 1
2022-02-23 8-K 8-K 2.02,9.01 0001127537-22-000003 001-39562 22663565 34 324862 1 1
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011844 9398
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037068 005-91741 22621180 34 231892
2022-02-11 SC 13G/A e621287_sc13ga-pulmonx.htm 0001193805-22-000241 005-91741 22620930 34 98574
2022-02-11 SC 13G SEC SCHEDULE 13G 0001422849-22-000129 005-91741 22619955 34 18194
2022-02-11 SC 13G CHAMPLAIN 13G TICKER LUNG 0001315478-22-000019 005-91741 22617753 34 10667
2022-02-10 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-22-000736 005-91741 22612497 34 27810
2022-02-10 SC 13G SCHEDULE 13G 0001104659-22-018392 005-91741 22610667 34 12950
2022-02-04 SC 13G us7458481014_020422.txt 0000834237-22-007206 005-91741 22593446 34 13338
2022-02-03 SC 13G/A SCHEDULE 13G/A 0001104659-22-011355 005-91741 22588179 34 46528
2022-01-24 4 FORM 4 SUBMISSION 0001209191-22-004643 10465
2021-12-17 4 FORM 4 SUBMISSION 0001209191-21-070463 7339
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-070066 7344
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-070035 8935
2021-12-09 SC 13G/A SC 13G/A 0001104659-21-147985 005-91741 211481104 34 51444
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067999 4832
2021-12-03 4/A FORM 4/A SUBMISSION 0001209191-21-067997 11801
2021-12-03 4/A FORM 4/A SUBMISSION 0001209191-21-067978 11801
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067972 4809
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067971 4837
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067970 4868
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066199 10487
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064854 5284
2021-11-09 10-Q 10-Q 0001127537-21-000048 001-39562 211392311 34 10314449 1 1
2021-11-02 8-K 8-K 2.02,9.01 0001127537-21-000045 001-39562 211371224 34 329590 1 1
2021-10-22 4 FORM 4 SUBMISSION 0001209191-21-061431 7360
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060779 5285
2021-09-21 4 FORM 4 SUBMISSION 0001209191-21-057147 9481
2021-09-20 4 FORM 4 SUBMISSION 0001209191-21-056974 10163
2021-09-17 4 FORM 4 SUBMISSION 0001209191-21-056727 5284
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054861 4868
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054860 5042
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054858 4809
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054857 5747
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054854 4764
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054851 4764
2021-08-23 4 FORM 4 SUBMISSION 0001209191-21-053007 7625
2021-08-18 4 FORM 4 SUBMISSION 0001209191-21-052427 5305
2021-08-10 10-Q 10-Q 0001127537-21-000041 001-39562 211160531 34 9030788 1 1
2021-08-03 3 FORM 3 SUBMISSION 0001209191-21-049483 6560
2021-08-03 3 FORM 3 SUBMISSION 0001209191-21-049482 6560
2021-08-03 8-K 8-K 2.02,9.01 0001127537-21-000037 001-39562 211139721 34 327983 1 1
2021-08-02 8-K 8-K 5.02 0001127537-21-000033 001-39562 211134915 34 177860 1 1
2021-07-19 4 FORM 4 SUBMISSION 0001209191-21-047262 8925
2021-07-19 4 FORM 4 SUBMISSION 0001209191-21-047261 18994
2021-07-16 SC 13G e620801_sc13g-pulmonx.htm 0001193805-21-001032 005-91741 211095335 34 98048
2021-07-14 4 xslF345X03/doc4.xml 0001225208-21-010646 4664
2021-07-13 4 FORM 4 SUBMISSION 0001209191-21-046602 5589
2021-06-28 4 FORM 4 SUBMISSION 0001209191-21-043518 6098
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042216 13487
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040077 7443
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040076 7208
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040074 4844
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040072 6087
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040071 7180
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040070 8324
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040068 5620
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040067 5818
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040066 4820
2021-05-25 4 FORM 4 SUBMISSION 0001209191-21-035741 10192
2021-05-21 4 FORM 4 SUBMISSION 0001209191-21-035021 9976
2021-05-21 8-K 8-K 5.07 0001127537-21-000027 001-39562 21949578 34 186360 1 1
2021-05-19 4 FORM 4 SUBMISSION 0001209191-21-034061 6931
2021-05-14 S-8 S-8 0001127537-21-000024 333-256140 21924793 33 241197
2021-05-12 10-Q 10-Q 0001127537-21-000018 001-39562 21915424 34 28498731 1 1
2021-05-11 4 FORM 4 SUBMISSION 0001209191-21-031854 10484
2021-05-04 8-K 8-K 2.02,9.01 0001127537-21-000015 001-39562 21888518 34 301646 1 1
2021-04-21 4 FORM 4 SUBMISSION 0001209191-21-027833 5304
2021-04-16 4 FORM 4 SUBMISSION 0001209191-21-026985 9480
2021-04-09 DEFA14A DEFA14A 0001193125-21-111555 001-39562 21817843 34 31657
2021-04-09 DEF 14A DEF 14A 0001193125-21-111545 001-39562 21817808 34 347168
2021-04-08 5 FORM 5 SUBMISSION 0001209191-21-026141 7053
2021-04-08 3/A FORM 3/A SUBMISSION 0001209191-21-026140 4392
2021-04-08 4 xslF345X03/doc4.xml 0001225208-21-006650 4661
2021-04-07 4/A FORM 4/A SUBMISSION 0001209191-21-025997 7678
2021-04-06 4 FORM 4 SUBMISSION 0001209191-21-025748 7363
2021-04-06 4 FORM 4 SUBMISSION 0001209191-21-025747 13573
2021-04-01 4 xslF345X03/doc4.xml 0001225208-21-006217 4636
2021-03-24 8-K 8-K 5.02 0001127537-21-000012 001-39562 21768434 34 179420 1 1
2021-03-15 10-K 10-K 0001127537-21-000008 001-39562 21742056 34 32671882 1 1
2021-03-02 8-K 8-K 2.02,9.01 0001127537-21-000002 001-39562 21703473 34 334533 1 1
2021-02-12 SC 13G SC 13G 0001104659-21-022017 005-91741 21628573 34 37685
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-041547 005-91741 21627592 34 262141
2020-12-08 3 FORM 3 SUBMISSION 0001209191-20-062176 6600
2020-12-08 3 FORM 3 SUBMISSION 0001209191-20-062171 6569
2020-11-13 10-Q 10-Q 0001127537-20-000010 001-39562 201312083 34 10596230 1 1
2020-11-10 8-K 8-K 2.02,9.01 0001127537-20-000006 001-39562 201301134 34 331131 1 1
2020-10-13 SC 13G d8630907_13g.htm 0000919574-20-006300 005-91741 201234950 34 345718
2020-10-07 3 FORM 3 SUBMISSION 0001209191-20-054170 8029
2020-10-05 4 xslF345X03/doc4.xml 0001225208-20-012257 27451
2020-10-05 4 FORM 4 0001628280-20-014288 4741
2020-10-05 4 FORM 4 0001628280-20-014287 26882
2020-10-05 4 FORM 4 0001628280-20-014285 4519
2020-10-05 4 FORM 4 0001628280-20-014283 16967
2020-10-05 4 FORM 4 0001628280-20-014282 26675
2020-10-05 8-K 8-K 5.03,9.01 0001628280-20-014280 001-39562 201223605 34 78496
2020-10-02 4 FORM 4 0001628280-20-014200 5422

Latest XBRL company facts

One latest value per concept from companyfacts (369 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 43.55M 2026-10-29 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
dei EntityPublicFloat Entity Public Float USD 101.40M 2025-06-30 2025 FY 10-K 2026-03-10 0001127537-26-000015
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001140361-26-016105
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.22M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001140361-26-016105
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 3.2 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001140361-26-016105
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 12.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 4.91M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 171,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 14.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.29M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 586.13M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.80M 2020-05-01 2020-05-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.10M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AdvertisingExpense Advertising Expense USD 10.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 11.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 100,000 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 301,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001127537-22-000022
us-gaap Assets Assets USD 110.21M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AssetsCurrent Assets, Current USD 84.06M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 31,000 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 8,000 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 46.20M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001127537-23-000036
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001127537-25-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001127537-25-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2024-06-30 2024 Q2 10-Q 2024-08-02 0001127537-24-000077
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001127537-25-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 44.39M 2024-09-30 2024 Q3 10-Q 2024-11-01 0001127537-24-000087
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 44.47M 2024-09-30 2024 Q3 10-Q 2024-11-01 0001127537-24-000087
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 46.02M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001127537-23-000036
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 33.57M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001127537-23-000036
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 12.45M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001127537-23-000036
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CapitalizedComputerSoftwareImpairments1 Capitalized Computer Software, Impairments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap Cash Cash USD 52.13M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 52.69M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 202.60M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001127537-21-000048
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 52.95M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -17.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 9.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 10.57 2019-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 215,291 2019-03-01 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2021-09-30 2021 Q3 10-Q 2021-11-09 0001127537-21-000048
us-gaap CommercialPaperAtCarryingValue Commercial Paper, at Carrying Value USD 749,000 2025-06-30 2025 Q2 10-Q 2025-08-01 0001127537-25-000045
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 15.13M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 43.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 43.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CommonStockValue Common Stock, Value, Issued USD 44,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -32.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 12,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ConvertibleDebt Convertible Debt USD 29.75M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001127537-20-000010
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 14.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 645,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 61.44M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 400,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-04 0001127537-26-000025
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 100,000 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestWriteoff Debt Securities, Available-for-Sale, Accrued Interest Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-06-30 2023 Q2 10-Q 2023-08-04 0001127537-23-000036
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss USD 30.55M 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 5.66M 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 8,000 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 5.66M 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 8,000 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 37,000 2023-12-31 2023 FY 10-K 2024-02-27 0001127537-24-000024
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 1.60M 2019-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -19,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -19,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 4.73M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 71,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 3.06M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 105.15M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 6.31M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 4.66M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 76.65M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.26M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 380,000 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 7.62M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 100.49M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 69,000 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill Deferred Tax Liabilities, Goodwill USD 569,000 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 0 1997-10-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap Depreciation Depreciation USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -3.16 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.155 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 199,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.057 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.055 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.002 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -224,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 3.90M 2020-04-30 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 56.20M 2022-03-31 2022 Q1 10-Q 2022-05-09 0001127537-22-000022
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 41.60M 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 68,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 68,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 277,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 345,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.82M 2023-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 31,000 2023-12-31 2023 FY 10-K 2024-02-27 0001127537-24-000024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 31,000 2023-09-30 2023 Q3 10-Q 2023-11-03 0001127537-23-000048
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 31,000 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 31,000 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 31,000 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.85M 2023-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2024-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap Goodwill Goodwill USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001127537-23-000018
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2023-03-31 2023 Q1 10-Q 2023-05-08 0001127537-23-000018
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001127537-23-000018
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001127537-23-000018
us-gaap GrossProfit Gross Profit USD 51.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -57.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -31.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 3.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 496,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 433,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -203,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -11.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 269,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -104,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 26,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 170,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 614,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 174,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -104,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 157,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 634,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -955,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 24,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -267,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InterestExpense Interest Expense USD 883,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-03 0001127537-24-000052
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 18.18M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 14.02M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryNet Inventory, Net USD 15.44M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 3.79M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 4.44M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 764,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InventoryWriteDown Inventory Write-down USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap LeaseCost Lease, Cost USD 2.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 27.60M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 14.84M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.94M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.97M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 771,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 9.07M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap Liabilities Liabilities USD 76.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 110.21M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LiabilitiesCurrent Liabilities, Current USD 20.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 90,000 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap LongTermDebt Long-term Debt USD 37.81M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 3.31M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001127537-21-000048
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 91,000 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 3.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 5.00M 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 4.49M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 958,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 37.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 455,000 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap MarketableSecurities Marketable Securities USD 0 2020-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap MediumTermNotes Medium-term Notes USD 17.23M 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 555,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -18.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -32.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -32.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -32.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NoncurrentAssets Long-Lived Assets USD 1.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap NumberOfReportingUnits Number of Reporting Units segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap OperatingExpenses Operating Expenses USD 80.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -29.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.53M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.14M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 17.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.099 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 474,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap OtherAssetsCurrent Other Assets, Current USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 1,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -334,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 657,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001127537-22-000053
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 212,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 476,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001127537-24-000024
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 507,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PrepaidInsurance Prepaid Insurance USD 939,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 38.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001127537-25-000012
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001127537-21-000048
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ProceedsFromRepaymentOfLoansToPurchaseCommonStock Proceeds from Repayment of Loans to Purchase Common Stock USD 403,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 45,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 9.05M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 100,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap RepaymentsOfDebt Repayments of Debt USD 37.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 52,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RepaymentsOfMediumTermNotes Repayments of Medium-term Notes USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 14.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RestrictedCash Restricted Cash USD 257,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 231,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001127537-20-000010
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -553.69M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 66.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 200,000 2023-04-01 2023-04-30 2024 Q1 10-Q 2024-05-03 0001127537-24-000052
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 219,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 65.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 13.44 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 485,054 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 128,395 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.86 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.55 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.10M 2024-09-30 2024 Q3 10-Q 2024-11-01 0001127537-24-000087
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 15.59 2024-09-30 2024 Q3 10-Q 2024-11-01 0001127537-24-000087
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 16.55 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 17.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 2.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 12.22 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 8.29 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap ShortTermBorrowings Short-term Debt USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 34.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2020-09-22 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 251,133 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 29,866 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 207.60M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 202,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.88M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 414 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001127537-20-000010
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001127537-23-000018
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 100,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 848,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2020-10-05 2022 FY 10-K 2023-03-01 0001127537-23-000011
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2020-12-31 2020 FY 10-K 2021-03-15 0001127537-21-000008
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 2.26M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.07M 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 51,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 158,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 4.00M 2024-03-31 2024 Q1 10-Q 2024-05-03 0001127537-24-000052
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 9.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 512,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap VariableLeaseCost Variable Lease, Cost USD 410,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 345,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 42.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 35.37M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001127537-21-000018
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 40.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001127537-26-000015
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 42.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001127537-26-000048
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001127537-22-000013

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →